These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 29868972)

  • 1. A global perspective on vasoactive agents in shock.
    Annane D; Ouanes-Besbes L; de Backer D; DU B; Gordon AC; Hernández G; Olsen KM; Osborn TM; Peake S; Russell JA; Cavazzoni SZ
    Intensive Care Med; 2018 Jun; 44(6):833-846. PubMed ID: 29868972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive variability in vasoactive agent therapy: a nationwide survey in Chinese intensive care units.
    Pei XB; Ma PL; Li JG; Du ZH; Zhou Q; Lu ZH; Yun L; Hu B
    Chin Med J (Engl); 2015 Apr; 128(8):1014-20. PubMed ID: 25881592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit.
    Jentzer JC; Coons JC; Link CB; Schmidhofer M
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):249-60. PubMed ID: 25432872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive drugs in the intensive care unit.
    Holmes CL
    Curr Opin Crit Care; 2005 Oct; 11(5):413-7. PubMed ID: 16175026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
    Jia L; Wang P; Li C; Xie J
    Shock; 2023 Dec; 60(6):746-752. PubMed ID: 37548686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive drugs for vasodilatory shock in ICU.
    Holmes CL; Walley KR
    Curr Opin Crit Care; 2009 Oct; 15(5):398-402. PubMed ID: 19542884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressors and Inotropes in Sepsis.
    Stratton L; Berlin DA; Arbo JE
    Emerg Med Clin North Am; 2017 Feb; 35(1):75-91. PubMed ID: 27908339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive Agents for Adult Septic Shock: An Update and Review.
    Dalimonte MA; DeGrado JR; Anger KE
    J Pharm Pract; 2020 Aug; 33(4):523-532. PubMed ID: 31057085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressors and inotropes in the treatment of human septic shock: effect on innate immunity?
    Hartemink KJ; Groeneveld AB
    Inflammation; 2012 Feb; 35(1):206-13. PubMed ID: 21347606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The medical treatment of cardiogenic shock: cardiovascular drugs.
    De Backer D; Arias Ortiz J; Levy B
    Curr Opin Crit Care; 2021 Aug; 27(4):426-432. PubMed ID: 33797431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
    Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
    J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of patients on multiple vasoactive drugs for shock.
    Prys-Picard CO; Shah SK; Williams BD; Cardenas V; Sharma G
    J Intensive Care Med; 2013; 28(4):237-40. PubMed ID: 22733722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin effective in reversing catecholamine-resistant vasodilatory shock.
    Lim TW; Lee S; NG KS
    Anaesth Intensive Care; 2000 Jun; 28(3):313-7. PubMed ID: 10853217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of vasoactive drugs on intestinal functional capillary density in endotoxemic rats: intravital video-microscopy analysis.
    Nacul FE; Guia IL; Lessa MA; Tibiriçá E
    Anesth Analg; 2010 Feb; 110(2):547-54. PubMed ID: 20081137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
    Oba Y; Lone NA
    J Crit Care; 2014 Oct; 29(5):706-10. PubMed ID: 24857641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive drug support in septic shock.
    Dries DJ
    Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528
    [No Abstract]   [Full Text] [Related]  

  • 17. The Use of Cardiotonic Drugs in Neonates.
    Dempsey E; Rabe H
    Clin Perinatol; 2019 Jun; 46(2):273-290. PubMed ID: 31010560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding vasoactive medications: focus on pharmacology and effective titration.
    Allen JM
    J Infus Nurs; 2014; 37(2):82-6. PubMed ID: 24583937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive drugs and splanchnic perfusion in septic shock.
    Uusaro A; Takala J
    Crit Care Med; 1998 Aug; 26(8):1458-60. PubMed ID: 9710110
    [No Abstract]   [Full Text] [Related]  

  • 20. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
    Bauer SR; Sacha GL; Reddy AJ
    Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.